Aarkstore Enterprise || Chlamydia Infections – Pipeline Review, H1 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Chlamydia Infections – Pipeline Review, H1 2012
http://www.aarkstore.com/reports/Chlamydia-Infections-Pipeline-Review-
H1-2012-208290.html
RSS link of Global Markets Direct
Summary
Global Markets Direct’s, Chlamydia Infections - Pipeline Review, H1 2012, provides
an overview of the Chlamydia Infections therapeutic pipeline. This report provides
information on the therapeutic development for Chlamydia Infections, complete
with latest updates, and special features on late-stage and discontinued projects. It
also reviews key players involved in the therapeutic development for Chlamydia
Infections. Chlamydia Infections - Pipeline Review, H1 2012 is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Chlamydia Infections.
- A review of the Chlamydia Infections products under development by companies
and universities/research institutes based on information derived from company
and industry-specific sources.
- Coverage of products based on various stages of development ranging from

2. discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Chlamydia Infections Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Chlamydia Infections 7
Chlamydia Infections Therapeutics under Development by Companies 9
Chlamydia Infections Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Chlamydia Infections Therapeutics – Products under Development by Companies 14
Chlamydia Infections Therapeutics – Products under Investigation by
Universities/Institutes 15
Companies Involved in Chlamydia Infections Therapeutics Development 16
Emergent BioSolutions Inc. 16
CEL-SCI Corporation 17
Creative Antibiotics Sweden AB 18
Osel Inc. 19
Genetic Immunity, LLC 20
Genocea Biosciences, Inc. 21

3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Subarachnoid Hemorrhage – Pipeline Review, H1 2012
Lung Injury – Pipeline Review, H1 2012
Birch Pollen Allergy – Pipeline Review, H1 2012
Chlamydia Infections – Pipeline Review, H1 2012
Auto Inflammatory Disease – Pipeline Review, H1 2012
Auto Inflammatory Disease – Pipeline Review, H1 2012
Orthostatic Hypotension – Pipeline Review, H1 2012
Hypoparathyroidism – Pipeline Review, H1 2012
Grass Pollen Allergy – Pipeline Review, H1 2012
Search More Reports Related to This Category :

4. Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com